Isobutyl hexanoate, 97%, 500g

3,5-Di-tert-butylphenyl acrylate, 97%, 10g

Methyl 4-chloronicotinate hydrochloride, 95.0%, 1g

2-BROMO-3-METHOXYBENZALDEHYDE, 95.0%, 1g

6,11-Dihydro-5H-dibenzo[b,e]azepine, 95+%, 1g

(2,6-Difluoropyridin-4-yl)boronic acid, 95.0%, 25g

Linsitinib, 100mg

2,3-Dimethyl-2H-indazol-6-amine hydrochloride, 95.0%, 100g

(5-Chloro-2-hydroxyphenyl)boronic Acid (contains varying amounts of Anhydride)1g

Acide chlorhydrique, 20%, technique, 10 l, emballage plastique.

Fmoc-(S)-3-Amino-3-(3-trifluoromethyl-phenyl)-propionic acid, 97%, 1g

5-Bromo-3-fluoropyridine-2-carboxylic acid, 95.0%, 10g

3-(Methylsulfonyl)propan-1-ol, 95.0%, 5g